BiotechTube
Home/Neuromagen Pharma/Prof. Esther Priel, DSc
PE

Prof. Esther Priel, DSc

Founder, CEO & CSO

Neuromagen Pharma

Therapeutic Areas

NeurodegenerationAlzheimer's diseaseCardiovascular agingMetabolic diseaseReproductive healthHair and skin rejuvenationAnti‑aging

Neuromagen Pharma Pipeline

DrugIndicationPhase
AGS‑499Amyotrophic Lateral Sclerosis (ALS)Preclinical

Leadership Team at Neuromagen Pharma

DD
Daniella Dayan, B.Sc., MBA
Chief Operating Officer
DH
Dr. Helena Grinberg‑Rashi, Ph.D., MBA
Senior Clinical and Regulatory Advisor
DE
Dr. Elad Bar Gil, MD
Chief Medical Officer
DH
Dr. Hananel Elul, Ph.D.
Researcher
DT
Dr. Tatyana Glukovsky, Ph.D.
Researcher
PG
Prof. Gal Ifergane, MD
Scientific Advisory Board, Head of Brain Medicine Division
PD
Prof. David Stepensky, Ph.D.
Scientific Advisory Board
MI
Mr. Iftach Seri, M.Sc., MBA
CEO, CTS Ltd.
View full Neuromagen Pharma profile